Aktie A1C7Z4 UNICHEM LABORATORIES LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Unichem Laboratories Limited

Aktien

A1C7Z4

INE351A01035

UNICHEMLAB

Markt geschlossen - Bombay S.E.
Andere Börsenplätze
 12:00:47 10.05.2024 		% 5 Tage % 1. Jan.
566,1 INR +1,92 % Intraday Chart für Unichem Laboratories Limited -3,23 % +39,13 %
29.03. Unichem Laboratories Limited kündigt Rücktritte aus dem Vorstand mit Wirkung zum 31. März 2024 an CI
27.03. Unichem Laboratories Chief Commercial and International Business Development Officer tritt zurück MT

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Unichem Laboratories Limited Announces Board Resignations, Effective March 31, 2024
Unichem Laboratories Chief Commercial and International Business Development Officer Steps Down
Unichem Laboratories Limited Announces Resignation of Santosh Mahil as Chief Commercial & International Business Development Officer
Unichem Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Indian Equities Close Marginally Higher Ahead of IT Earnings
Unichem Laboratories Gets US FDA Approval for Generic Hypertension Drug
Unichem Laboratories Limited Receives Anda Approval for Its Doxazosin Tablets USP, 1 Mg, 2 Mg, 4 Mg and 8 Mg
Unichem Laboratories Completes Sale of Entire Stake in Optimus Drugs
Unichem Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Ipca Laboratories Limited completed the acquisition of 19.29% stake in Unichem Laboratories Limited for INR 6 billion.
Unichem Laboratories : Disclosure on ESOP 2023
Unichem Laboratories : Newspaper advertisement for Notice of 60th Annual General Meeting and Remote E-Voting
Unichem Laboratories : Draft Annual Return 2022-23
Unichem Laboratories Gets US FDA Nod for Prasugrel Tablets
Unichem Laboratories Limited Receives ANDA Approval for its Prasugrel Tablets USP, 5 Mg and 10 Mg from the United States Food and Drug Administration
Unichem Laboratories : Newspaper advertisement for Notice to the Members of the 60th Annual General Meeting through Video Conference (‘VC’)/ Other Audio Visual Means (‘OVAM’)
Unichem Laboratories : Annual Report – 2022-23
Unichem Laboratories Limited Announces the Resignation of Dilip Kunkolienkar as Member of the Audit Committee and Risk Management Committee of the Board of Directors
Ipca Laboratories Acquires 33% Stake in Unichem for INR9.45 Billion
Unichem Laboratories : News paper Publication of Financial Results for quarter ended 30.6.2023
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A1C7Z4 Aktie
  4. Nachrichten Unichem Laboratories Limited
  5. Andere Sprachen